Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients
OBJECTIVES: To describe the cumulative incidences of adverse drug reactions (ADRs) associated with disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients from real-world data (RWD), using the DREAM-RA registry, and to compare these with incidence frequencies mentioned in the Summary of Product Characteristics (SmPC). METHODS: All ADRs in patients with recorded use of adalimumab, etanercept, hydroxychloroquine, leflunomide, oral and subcutaneous methotrexate, and sulfasalazine from a single center participating in the DREAM-RA registry (n = 1,098 patients) that we... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2020 |
Reihe/Periodikum: | Giraud , E L , Jessurun , N T , van Hunsel , F P A M , van Puijenbroek , E P , van Tubergen , A , Ten Klooster , P M & Vonkeman , H E 2020 , ' Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients ' , Expert Opinion on Drug Safety , vol. 19 , no. 12 , pp. 1617-1624 . https://doi.org/10.1080/14740338.2020.1830058 ; ISSN:1474-0338 |
Schlagwörter: | Adverse Drug Reaction Reporting Systems/statistics & numerical data / Aged / 80 and over / Antirheumatic Agents/administration & dosage / Arthritis / Rheumatoid/drug therapy / Female / Humans / Incidence / Male / Middle Aged / Netherlands / Pharmacovigilance / Registries |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27600834 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/11370/647567e5-5254-4d32-aa60-e2196dcef91f |